Short Interest in Eyenovia, Inc. (NASDAQ:EYEN) Increases By 65.9%

Eyenovia, Inc. (NASDAQ:EYEN) was the recipient of a significant increase in short interest during the month of November. As of November 15th, there was short interest totalling 3,550,000 shares, an increase of 65.9% from the October 31st total of 2,140,000 shares. Based on an average daily volume of 4,600,000 shares, the short-interest ratio is presently 0.8 days.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Brookline Capital Management reiterated a “hold” rating on shares of Eyenovia in a research report on Friday, November 15th. HC Wainwright lowered shares of Eyenovia from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $12.00 to $2.00 in a report on Monday, November 18th. William Blair reaffirmed a “market perform” rating on shares of Eyenovia in a report on Friday, November 15th. Finally, LADENBURG THALM/SH SH reissued a “neutral” rating on shares of Eyenovia in a research note on Monday, November 18th.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Eyenovia in the 2nd quarter worth about $26,000. Ground Swell Capital LLC purchased a new stake in Eyenovia in the second quarter worth about $27,000. Nations Financial Group Inc. IA ADV boosted its position in Eyenovia by 24.4% during the 2nd quarter. Nations Financial Group Inc. IA ADV now owns 50,900 shares of the company’s stock valued at $30,000 after acquiring an additional 10,000 shares in the last quarter. Financial Management Network Inc. purchased a new position in shares of Eyenovia during the 3rd quarter worth approximately $39,000. Finally, SkyView Investment Advisors LLC purchased a new position in shares of Eyenovia during the 2nd quarter worth approximately $87,000. Institutional investors own 25.84% of the company’s stock.

Eyenovia Price Performance

Shares of Eyenovia stock opened at $0.10 on Friday. The stock has a market capitalization of $8.56 million, a P/E ratio of -0.14 and a beta of 1.75. Eyenovia has a one year low of $0.08 and a one year high of $2.57. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.74 and a quick ratio of 0.55. The business’s 50 day simple moving average is $0.40 and its two-hundred day simple moving average is $0.66.

Eyenovia (NASDAQ:EYEN) last posted its quarterly earnings results on Tuesday, November 12th. The company reported ($0.11) EPS for the quarter, beating analysts’ consensus estimates of ($0.13) by $0.02. Eyenovia had a negative net margin of 114,639.41% and a negative return on equity of 1,108.24%. During the same quarter last year, the company posted ($0.18) earnings per share. Analysts forecast that Eyenovia will post -0.5 EPS for the current year.

About Eyenovia

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.